is part of the Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Trelleborg Expands Medtech Capabilities with EirMed Acquisition

Image: XtravaganT/Adobe Stock M&A illustration with target and arrow
Purchase of the Wisconsin-based injection molder opens the bioresorbables and dental markets for Trelleborg.

Sweden's Trelleborg Group announced today that it has finalized the acquisition of EirMed LLC. Based in Menomonie, WI, EirMed specializes in technical plastic injection-molded components primarily for medical device OEMs. The parts are typically used with in-vitro diagnostic, minimally invasive surgical, and orthopedic devices. The deal was finalized on April 25 through Trelleborg’s US-based business arm, Trelleborg Sealing Solutions,

The bolt-on acquisition will become part of Trelleborg Healthcare & Medical, a single-source supplier providing medical device manufacturers with the materials, components, and processes needed to deliver finished devices to market.  

“Trelleborg Healthcare & Medical is globally known for our silicone rubber capabilities. We have also been recognized by key customers as their thermoplastic molding supplier of choice,” commented Linda Muroski, President of Trelleborg Global Healthcare & Medical, in a prepared statement. “Part of our strategy is to expand our capabilities beyond thermoplastic molding and liquid silicone rubber. To that end, EirMed is a much-needed addition to our business, bringing extensive medical device assembly experience and expanding our capabilities and capacity in thermoplastics. EirMed enables us to enter markets where we previously have not had a presence, specifically the bioresorbable and dental markets,” added Muroski.

The acquisition is aligned with an industry trend toward supply-chain simplification, noted EirMed President Rick Curtis. “We have customers asking us all the time to simplify their supply chain to provide more value. Trelleborg has the capability to support customers from feasibility and prototyping to automation, serial production, and all the phases of development and manufacturing in between. Our acquisition will be viewed extremely positively by our customers, because it says to them that we are going to be your partner regardless of where you fall in that spectrum,” said Curtis.

Muroski added that she is “excited about our ability to now offer customers fully integrated solutions for finished medical devices. We can take customers from design and concept at our Rapid Development Center to annuity business, making all components in-house. This reduces the need for customers to manage outside vendors, greatly simplifying their supply chains.”

Trelleborg Healthcare & Medical now comprises seven manufacturing facilities in the Americas and Europe, as well as a Rapid Development Center and its global headquarters in the Minneapolis area. Capabilities include silicone molding, extrusion, sheeting, dipping, and coating; overmolding; plastic injection molding; multicomponent manufacturing; drug-eluting technologies; and engineered coated fabrics.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish